Intuitive Surgical, Inc. $ISRG Shares Purchased by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA increased its stake in Intuitive Surgical by 12.1%, owning 37,768 shares worth approximately $20.52 million as of the latest reporting period.
• Intuitive Surgical reported a 21.4% year-over-year revenue increase of $2.44 billion for the quarter, outperforming analysts' estimates.
• Investment firms have issued mixed ratings for Intuitive Surgical, with thirteen analysts recommending a Buy rating and a consensus price target of $595.95.

Banque Pictet & Cie SA raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 37,768 shares of the medical equipment provider's stock after buying an additional 4,085 shares during the period. Banque Pictet & Cie SA's holdings in Intuitive Surgical were worth $20,524,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC boosted its stake in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter worth $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Finally, TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after buying an additional 45 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $438.12 on Friday. The stock has a 50 day moving average of $470.98 and a 200 day moving average of $501.82. The firm has a market capitalization of $157.06 billion, a price-to-earnings ratio of 61.10, a PEG ratio of 4.65 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the business earned $1.78 earnings per share. The company's revenue for the quarter was up 21.4% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the transaction, the director directly owned 739 shares of the company's stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ISRG. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. UBS Group boosted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. BTIG Research increased their price target on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Finally, Evercore ISI raised their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.